Skip to main navigation Skip to search Skip to main content

Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML)

Translated title of the contribution: Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML)
  • B. Löwenberg
  • , S. Suciu
  • , E. Archimbaud
  • , G. Ossenkoppele
  • , G.E.G. Verhoef
  • , E. Vellenga
  • , P.W. Wijermans
  • , Z. Berneman
  • , A.W. Dekker
  • , P. Stryckmans
  • , H.C. Schouten
  • , U. Jehn
  • , P. Muus
  • , P. Sonneveld
  • , M. Dardenne
  • , R. Zittoun

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionUse of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML)
Original languageUndefined/Unknown
Pages (from-to)2952-2961
Number of pages10
JournalBlood
Volume90
Publication statusPublished - 1997

Keywords

  • Econometric and Statistical Methods: General
  • Geneeskunde(GENK)
  • Algemeen onderzoek
  • Immunology

Cite this